NasdaqCM - Delayed Quote USD
UFP Technologies, Inc. (UFPT)
206.80
-0.09
(-0.04%)
At close: April 25 at 4:00:01 PM EDT
206.80
0.00
(0.00%)
After hours: April 25 at 4:05:14 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
504,421
504,421
400,072
353,792
206,320
Cost of Revenue
357,728
357,728
287,847
263,532
155,206
Gross Profit
146,693
146,693
112,225
90,260
51,114
Operating Expense
62,218
62,218
50,889
45,796
29,480
Operating Income
84,475
84,475
61,336
44,464
21,634
Net Non Operating Interest Income Expense
-8,061
-8,061
-3,645
-2,763
-39
Other Income Expense
-3,389
-3,389
-3,789
11,017
-390
Pretax Income
73,025
73,025
53,902
52,718
21,205
Tax Provision
14,044
14,044
8,978
10,929
5,319
Net Income Common Stockholders
58,981
58,981
44,924
41,789
15,886
Diluted NI Available to Com Stockholders
58,981
58,981
44,924
41,789
15,886
Basic EPS
7.69
--
5.89
5.52
2.11
Diluted EPS
7.58
--
5.83
5.45
2.09
Basic Average Shares
7,668
--
7,624
7,564
7,524
Diluted Average Shares
7,785
--
7,701
7,663
7,615
Total Operating Income as Reported
80,897
80,897
57,664
55,400
21,218
Total Expenses
419,946
419,946
338,736
309,328
184,686
Net Income from Continuing & Discontinued Operation
58,981
58,981
44,924
41,789
15,886
Normalized Income
61,872.02
61,872.02
47,982.78
33,116.75
16,197.58
Interest Income
--
--
--
--
49
Interest Expense
8,061
8,061
3,645
2,763
39
Net Interest Income
-8,061
-8,061
-3,645
-2,763
-39
EBIT
81,086
81,086
57,547
55,481
21,244
EBITDA
95,801
95,801
68,954
67,367
29,654
Reconciled Cost of Revenue
357,728
357,728
287,847
263,532
155,206
Reconciled Depreciation
14,715
14,715
11,407
11,886
8,410
Net Income from Continuing Operation Net Minority Interest
58,981
58,981
44,924
41,789
15,886
Total Unusual Items Excluding Goodwill
-3,578
-3,578
-3,672
10,936
-416
Total Unusual Items
-3,578
-3,578
-3,672
10,936
-416
Normalized EBITDA
99,379
99,379
72,626
56,431
30,070
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-686.98
-686.98
-613.22
2,263.75
-104.42
12/31/2021 - 12/17/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HAE Haemonetics Corporation
62.51
+0.95%
STE STERIS plc
225.00
-0.60%
ITGR Integer Holdings Corporation
123.41
+1.61%
MODD Modular Medical, Inc.
0.9300
-0.64%
BVS Bioventus Inc.
7.65
-1.03%
AHCO AdaptHealth Corp.
8.41
+4.73%
BBNX Beta Bionics, Inc.
10.96
-0.90%
MYO Myomo, Inc.
4.8400
-0.82%
214150.KQ CLASSYS Inc.
63,500.00
0.00%
IRTC iRhythm Technologies, Inc.
105.99
+1.15%